10 Additionally, GLP1 RA use has notable challenges: frequent gastrointestinal side effects, risk for nutritional deficiencies, muscle and bone loss, high costs and limited accessibility
Retatrutide is a novel 'triple agonist' developed by Eli Lilly, targeting the GLP-1, GIP, and glucagon receptors simultaneously
The Power of Bitter Foods The Science: Your gut isnt just for digesting, but it is actually lined with bitter taste receptors (known as T2Rs) that are identical to the ones on your tongue
Two people climbed the Empire State Building to the very top (like, you-cant-actually-go-any-further-very-top), waved a flag with a message of love, and got engaged
Rosacea can flare throughout an individuals lifetime
Starting Semaglutide for weight loss can be exciting, but if youve never given yourself an injection before, you might feel a little nervous